How to Track MR Productivity in Pharma | FireAI

Tracking MR productivity in pharma means measuring whether medical representatives are reaching the right doctors, at the right frequency, with the right messages, and whether that activity translates into prescription movement and sales outcomes. Activity alone does not determine productivity. The link between field effort and business results is what makes MR tracking useful.

Indian pharma companies deploy large field forces, from a few hundred MRs in mid-size generics firms to 10,000-plus in major companies. Without structured tracking, managers rely on self-reported call data, monthly sales numbers, and gut feel. With it, they can identify coverage gaps early, coach underperformers against specific metrics, and deploy resources toward high-potential territories. For an overview of the full pharma analytics landscape, see pharma analytics in India.

Step 1: Define the six MR productivity metrics

Before tracking anything, align on exactly what you will measure. These six metrics form the standard MR productivity framework used by Indian pharma companies.

1. Calls per day

Calls per day is the number of doctor or chemist visits an MR completes in a working day.

• Indian pharma benchmark: 8 to 12 calls per day for most therapy areas
• Separate field calls (doctor visits) from back-office or admin time
• Track planned versus actual calls to reveal whether beat schedules are realistic or whether compliance is weak

2. Doctor coverage

Doctor coverage is the percentage of the target doctor universe that the MR actually visits in a period (typically one month).

• A-class doctors (highest prescribers): weekly visits
• B-class doctors: fortnightly visits
• C-class doctors: monthly visits

Coverage gaps by doctor class show where MR time is going versus where it should go.

3. Call frequency compliance

Call frequency compliance measures whether MRs are visiting each doctor at the planned cadence, not just hitting a total call count.

An MR may complete 250 calls in a month but spend 80% of them on easy C-class doctors while A-class doctors are under-visited. Frequency compliance catches this pattern by tracking visits per doctor against the classification target.

4. New doctor additions

New doctor additions tracks how many net-new prescribers the MR brings into the prescriber base each month.

• Benchmark: 5 to 10 new doctors per MR per month, depending on product lifecycle and therapy area
• New doctor additions are a leading indicator for brand growth, especially for recently launched products

5. Sales per MR

Sales per MR is the monthly revenue attributed to each representative's territory, measured at primary or secondary level depending on what your company tracks at MR level.

It is the headline metric for manager reviews but must be read alongside coverage and call frequency. A high sales figure may reflect an inherited strong territory rather than genuine productivity.

6. Input cost per call

Input cost per call is the total field cost (travel, samples, promotional material, salary allocation) divided by calls completed in a period.

It tracks whether productivity is improving or whether cost is rising faster than output, and enables cost-efficiency comparisons across regions and therapy divisions.

Step 2: Map your data sources

Accurate MR tracking requires three data streams working together.

SFA or CRM

The SFA system is the primary source for field activity: visit records, sample distribution, call notes, and the doctor master. Indian pharma SFA platforms include Medismart, Compass (Cegedim), Veeva CRM (used by MNCs), and custom-built mobile apps. SFA data gives you calls per day, frequency compliance, and doctor coverage.

Secondary sales from DMS or stockists

Distributor management system (DMS) data or stockist billing reports show territory-level offtake from the trade. This is the output you correlate with MR activity. Without secondary sales, you can only track effort, not outcomes.

ERP for primary billing

Primary billing from your ERP (SAP, Tally, or custom) shows what left the company to the C&F and stockist network. Primary is easier to track but lags behind prescription demand. Use it alongside secondary for a complete view of sales per MR.

Optional: IQVIA or AIOCD data

For companies with access to syndicated market data, Rx trend data from IQVIA or AIOCD can be linked at territory level. This identifies which MR activities drive actual prescription change, not just secondary billing movement.

Step 3: Build the MR scorecard

An MR scorecard combines the six metrics into a single performance view at territory and individual level.

Sample scorecard structure:

Metric	Target	Actual	Score
Calls per day	10	9.2	92%
A-class doctor coverage	90%	78%	78%
Call frequency compliance	85%	72%	72%
New doctors added	8	11	100%
Sales vs target	₹3.5 L	₹3.1 L	89%
Input cost per call	₹220	₹245	89%

Weighted scoring: Companies typically weight sales achievement and call frequency compliance most heavily (25 to 30% each), with the remaining metrics sharing the balance. The weighting should reflect your business priorities.

Territory adjustment: Compare MR scores within the same regional pool (similar doctor density, therapy category, and territory potential), not across structurally different geographies. An MR in a tier-1 city and one in a rural territory face different conditions.

Step 4: Set review cadence by management level

MR productivity data is only useful if it drives consistent action.

Daily (field manager level): Check SFA call counts and flag MRs who fell below 6 calls the previous day. This is an exception signal, not a punishment mechanism. Investigate before acting.

Weekly (ZSM and first-line manager level): Review weekly coverage compliance and call frequency by doctor class. Identify territories consistently underperforming on A-class coverage and arrange joint field working.

Monthly (RSM and NSM level): Full MR scorecard review. Rank MRs within each zone. Link productivity scores to sales outcomes to assess whether activity is converting. Adjust territory plans or call frequency targets if data shows structural mismatches.

Quarterly (sales head and analytics team): Cohort analysis of new doctor additions against prescription ramp-up. Evaluate whether input cost per call is improving. Review territory potential versus actual MR deployment.

Step 5: Address data quality before it corrupts tracking

Two data quality problems consistently undermine MR tracking in Indian pharma.

Inflated call reporting. MRs sometimes over-report calls when targets are evaluated on call counts. Geo-tagged SFA apps reduce this by requiring location verification at the time of call entry. Pair with joint field working audits to validate sample reports.

Doctor master quality. If the doctor database is incomplete, stale, or mapped to wrong territories, coverage metrics become meaningless. Assign ownership for doctor master maintenance to the ZSM or a dedicated field ops team, and review it quarterly.

Secondary data lag. Stockist billing data is often two to three weeks behind. Build review schedules to account for this lag rather than comparing real-time call data against month-old secondary numbers.

How FireAI helps pharma teams track MR productivity

Most pharma analytics teams spend hours each month merging SFA exports, DMS files, and ERP data in Excel before they can run a review. FireAI connects these sources directly so the MR productivity dashboard updates without manual stitching.

What FireAI connects:

• SFA or CRM exports (calls, doctor visits, sample distribution, territory master)
• Secondary sales from DMS or stockist files
• Primary billing from ERP
• Optional: IQVIA or AIOCD territory data where your license covers it

What you get:

• MR scorecards with all six metrics, updated as data refreshes
• Territory-level comparisons with benchmarks adjusted for doctor density and potential
• Call frequency compliance by doctor class, not just aggregate call counts
• Alerts when a territory drops below coverage thresholds before the monthly review
• Natural language queries so ZSMs and RSMs can ask, for example, which territories in Maharashtra have A-class doctor coverage below 70% this month, and get an answer without waiting for a central analytics team

For more on how AI connects these data sources, see can AI track pharma field force productivity. For the full dashboard design and KPI layout, see how to build a pharma sales dashboard.